RESUMO
The clinical records of 87 children with bacterial meningitis treated with antibiotics (group 1) and of 92 treated with antibiotics plus dexamethasone (group 2), admitted to the Instituto Materno Infantil de Pernambuco, Recife, Brazil over 2 consecutive years (1991 and 1992), were analysed. There were no significant differences between treatment groups regarding characteristics on admission except that group 1 were younger. The overall case fatality rate was 19%, with 14% in group 2 and 24% in group 1 (p = 0.09). Rate of discharge without sequelae was 70% in the steroid-treated children and 56% in children treated with antibiotics alone (p = 0.07). Among children aged 6-59 months, those treated with dexamethasone compared with those treated with antibiotics alone had a better case fatality rate (11% vs 25%; p = 0.05) and a better rate of discharge without sequelae (73% vs 52%; p = 0.02). Among the cases with a CSF culture positive for Haemophilus influenzae, 77% were discharged without sequelae in group 2 compared with 51% in group 1 (p = 0.03). The addition of dexamethasone to standard antibiotic treatment improves the outcome of children between 6 and 59 months of age admitted to hospital with a diagnosis of bacterial meningitis.
Assuntos
Antibacterianos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Dexametasona/uso terapêutico , Meningites Bacterianas/tratamento farmacológico , Adolescente , Antibacterianos/administração & dosagem , Anti-Inflamatórios/administração & dosagem , Brasil , Criança , Pré-Escolar , Países em Desenvolvimento , Dexametasona/administração & dosagem , Esquema de Medicação , Quimioterapia Combinada , Humanos , Lactente , Meningites Bacterianas/mortalidade , Meningite por Haemophilus/tratamento farmacológico , Meningite por Haemophilus/mortalidade , Estudos RetrospectivosAssuntos
Antibacterianos/uso terapêutico , Dexametasona/uso terapêutico , Meningites Bacterianas/tratamento farmacológico , Brasil/epidemiologia , Criança , Pré-Escolar , Países em Desenvolvimento , Quimioterapia Combinada , Humanos , Meningites Bacterianas/mortalidade , Moçambique/epidemiologia , Resultado do TratamentoRESUMO
El presente trabajo se de sarrolló en dos fases: en la primera los pdiatras respondieron a preguntas de un cuestionario, para poner en evidencia los tratamientos personales practicados en caso de Otitis Media Aguda (OMA) así como otitis media concaracter recurrente (ver cuadro 1). La segunda fase del trabajo consiste en evaluar críticamente cada uno de los estudios clínicos publicados sobre prevención farmacológica de OMAR y discutirlos en encuentros formales, de caracter colegial